IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

The immunosuppressive tumor microenvironment (TME) does not allow generation and expansion of antitumor effector cells. One of the potent immunosuppressive factors present in the TME is the indoleamine-pyrrole 2,3-dioxygenase (IDO) enzyme, produced mainly by cancer cells and suppressive immune cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandre, Rahul, Verma, Vivek, Gaur, Pankaj, Patil, Veerupaxagouda, Yang, Xingdong, Ramlaoui, Zainab, Shobaki, Nour, Andersen, Mads Hald, Pedersen, Ayako Wakatsuki, Zocca, Mai-Britt, Mkrtichyan, Mikayel, Gupta, Seema, Khleif, Samir N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381100/
https://www.ncbi.nlm.nih.gov/pubmed/35290437
http://dx.doi.org/10.1158/2326-6066.CIR-21-0457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381100/
https://www.ncbi.nlm.nih.gov/pubmed/35290437
http://dx.doi.org/10.1158/2326-6066.CIR-21-0457

Ejemplares similares